You are on page 1of 4

1. Noer MS. Sindrom nefotik idopatik.

Dalam: Noer MS, Soemyarso NA,


Subandiyah K, Prasetyo RV, Altas H, Tambunan T dkk. Kompendium nefrologi
anak. Jakarta: Badan penerbit ikatan dokter anak Indonesia. 2011:72-90.
2. Partini PT, Husein A, Taralan T, Sudung OP. Konsensus Tata laksana sindrom
nefrotik idiopatik pada anak. Jakarta: Badan penerbit IDAI. 2012:1-22.
3. Ali SH, Ali AM, Najim AH. The predictive factors for relapses in children with
steroid-sensitive nephrotic syndrome. Saudi J Kidney Dis Transpl. 2016;27:67-
72.
4. Davin J, Rutjes N. Nephrotic syndrome in children: From Bench to Treatment.
International Journal of Nephrology. 2011;10:1-6.
5. Uwaezoke SN. Steroid-sensitive nephrotic syndrome in children: trigger of
relapse and envolving hypotheses on pathogenesis. Ital J Pediatr.
2015;41(19):1-6.
6. Akcan-Arikan A, Zappitelli M, Loftis LL, dkk. Modified RIFLE criteria in critically
ill children with acute kidney injury. Kidney Int 2007; 71:1028.
7. Banh THM, Hussain-Shamsy N, Patel V, Vasilevska-Ristovska J, Borges K,
Sibbald C, dkk. Ethnic differences in incidence and outcomes of childhood
nephrotic syndrome. Clin J Am Soc Nephrol.2016;11:1760-8.
8. Kikunaga K, Ishikura K, Terano C, Sato M, Komaki F, Hamasaki Y, dkk. High
incidence of idiopathic nephrotic syndrome in East Asian children: a nationwide
survey in Japan (JP-SHINE) study. Clin Exp Nephrol. 2016; 16:1-7.
9. El BL, Rodrigues PR, Kuik DJ, Ket JC, van Wijk JA. Nephrotic syndrome in The
Netherlands: a population-based cohort study and a review of the literature.
Pediatr Nephrol. 2011; 26:1241–6.
10. Sarker M, Islam M, Saad T, Shoma F, Sharmin L, Khan HA, dkk. Risk factor for
relapse in childhood nephrotic syndrome: a hospital based retrospective study.

Faridpur Med Coll J. 2012; 7:18-22. 


11. Lombed RM, Gipson DS, Hodson EM. Treatment of steroid - sensitive nephrotic

syndrome: new guidelines from KDIGO. Pediatric Nephrol. 2013; 28:415-26. 


12. Rahman MH, J Esmin, Muinuddin G. An update of Management of idiopathic


nephrotic syndrome: a review article. Bangladesh J Child Health. 2013;37:102-
21.
13. Apais P, Avner ED. Nephrotic syndrome. Dalam: Nelson WE, Behrman RE,
Kliegman RM, Arvin AM, penyunting. Nelson textbook pf Pediatrics. Edisi ke-
20. Philadelphia: WB Saunders; 2016:2521-7.
14. Ellis D. Pathophysiology, evaluation, and management of edema in childhood

nephrotic syndrome. Front Pediatri. 2016;3:111. 


15. Teoh C, Robinson L, Noone D. Perspectives on edema in childhood nephrotic

syndrome. Am J Physiol Renal Physiol. 2015;309:575-82. 


16. Debbie SG, Susan FM, Lynne Y, Shashi N, William E, John DM, dkk.
Management of childhood onset nephrotic syndrome. AAP. 2009; 124:747-

55.


17. Sutherland SM, Byrnes JJ, Kothari M, dkk. AKI in hospitalized children:
comparing the pRIFLE, AKIN, and KDIGO definitions. Clin J Am Soc Nephrol
2015; 10:554.
18. Rheault RM, Zhang L, Selewski DT, Kallash M, dkk. AKI in Children
Hospitalized with Nephrotic Syndrome. Clin J Am Soc Nephrol. 2015;10:1-9.
19. Raja K, Parikh A, Webb H, Hotti D. Use of a low-dose prednisolone regimen to
treat a relapse of steroid-sensitive nephrotic syndrome in children. Pediatr
Nephrol. 2017;32(1):99-105.
20. Ulinski T, Aoun B. Pediatric idiopathic nephrotic syndrome: treatment strategies
in steroid dependent and steroid resistant forms. Curr Med Chem. 2010;17:847-
53.
21. Mbarek IB, Abroug S, Omezzine A, Pawtowski A, Gubler MC, Bouslama A.
Novel mutations in steroid-resistant neprotic syndrome diagnosed in tunisian
children. Pediatr Neprol. 2011;26:241-9.
22. Prescott WA, Streetman PA, Streetman DS. The potential role of HMG- CoA
reductase inhibitors in pediatric nephrotic syndrome. Ann Pharmacother.
2004;38:205-14.
23. Kong XY, Yuan H, Fan JM, Li I, Liu TX, Jiang LH. Lipid-lowering agents for
nephrotic syndrome. Cochrane Database Syst Rev. 2013;10:1-16.
24. Buemi N, Nostro L, Crasci E, Barilla A, Consentini V, Aloisi C, dkk. Statins in
nephrotic syndrome: a new weapon againts tissue injury. Med Res Rev.
2006;26:269-70.
25. Pardede SO, Puspitasari HA. Peritonitis bakterialis spontan pada anak dengan
sindrom nefrotik. CDK. 2013;40:265-8.
26. Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res.
2005;122:13-28.
27. Reni W, Eka L. Alternatif terapi inisial sindrom nefrotik untuk menurunkan
kejadian relaps. Sari Pediatri. 2010;11:415-9.
28. Ali S, Ali A, Najim A. The predictive factor of relapses in children with steroid-
sensitive nephrotic syndrome. Saudi J Kidney Dis Transpl. 2016;27:67-72.
29. Purnami NMA, Nilawati IGAP. Faktor risiko kekambuhan pasien sindrom
nefrotik. JIKA. 2013;2:39-48.
30. Paul SK, Islam QR, Uddin GM, Hassain MM. Infections in children with newly
diagnosed idiopathic nephrotic syndrome. CMOSHMCJ. 2013;12:1-4.
31. Gipson DS, Massengill SF,Yao L, Nagaraj S, Smoyer WE, Mahan JD, dkk.
Management of Childhood onset Nephrotic Syndrome.
Pediatrics.2009;124:747-57.
32. Katibi OS, Adedoyin OT, Anoba S, Sowunmi FO, Olorunsola BO, Ibrahim OR
dkk. Current trends in the management of acute kidney injury in children. Niger
J Paed 2013;40:314-20.
33. Sureshkumar P, Hodson EM, Willis NS, Barzi F, Craig JC. Predictors of
remission and relapse in idiopathic nephrotic syndrome: a prospective cohort
study. Pediatr Nephrol . 2014 Jun;29(6):1039 – 46.
34. Balaji J, Kumaravel K S, Punitha P, Sasikala K, Rameshbabu B. Risk factors
for relapse in childhood steroid sensitive nephrotic syndrome. Indian J Child
Health. 2017;4(3):322-6.
35. Basnet S, Poudel DR, Khanal S, Thapa NB. Nephrotic syndrome in Nepalese
children: clinical profile, histopathology, and outcome in a tertiary care center
of Nepal. J Ins Med. 2016; 38:15-9.
36. Mishra K, Kumar S, KanwalS, Veeranna S, Vikram B, Bimbadhar R. Predictors
of poor outcome in children with steroid sensitive nephrotic syndrome.
Nefrologia. 2017;462:1-5.
37. Abdel-Hafez MA, Abou-El-Hana NM, Erfan AA, El-Gamasy M, Abdel-Nabi H.
Predictive risk factors of steroid dependent nephrotic syndrome in children. J
Nephropathol. 2017;6(3):180-186.